Back to top

Image: Bigstock

Do Options Traders Know Something About Axsome (AXSM) Stock We Don't?

Read MoreHide Full Article

Investors in Axsome Therapeutics, Inc. (AXSM - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2019 $22.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Axsome shares, but what is the fundamental picture for the company? Currently, Axsome is a Zacks Rank #3 (Hold) in the Medical – Biomedical and Genetics industry that ranks in the Top 35% of our Zacks Industry Rank. Over the last 30 days, the Zacks Consensus Estimate for the current quarter has widened from a loss of 31 cents per share to a loss of 33 cents.

Given the way analysts feel about Axsome right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.

Click to see the trades now >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Axsome Therapeutics, Inc. (AXSM) - free report >>

Published in